Forbes contributors publish independent expert analyses and insights. Anisha Sircar is a journalist covering tech, finance and society. This voice experience is generated by AI. Learn more. This voice ...
SAN FRANCISCO, Jan 12 (Reuters) - Nvidia (NVDA.O), opens new tab and U.S. pharma giant Eli Lilly (LLY.N), opens new tab will spend $1 billion building a new joint research lab in the San Francisco Bay ...
Eli Lilly leads in the GLP-1 drug space with its shot-based offerings Mounjaro and Zepbound. Rival drugmaker Novo Nordisk has now introduced a pill version of its GLP-1 weight loss drug. Eli Lilly's ...
Top executives from drugmakers big and small told CNBC that the next phase of the obesity drug market will be defined by a broader range of treatment options and improved access for patients. CNBC ...
Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company's leading position is already being tested by Novo Nordisk's GLP-1 weight loss pill. Merck and Bristol Myers Squibb have ...
Eli Lilly (LLY) shares slipped ~5% on Thursday, marking what could be its biggest intraday loss in five months after Reuters reported that a potential FDA nod for the company’s weight loss pill, ...
Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. The facility ...
In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today's blockbuster injections ...
Hosted on MSN
Eli Tomac takes early command of the 2026 Supercross season with a victory in Anaheim 1
ANAHEIM, California: The first race of the season sets the tone for the 2026 SuperMotocross season, at least Eli Tomac hopes that is true as he held off Ken Roczen in the 2026 SuperMotocross World ...
Humana’s CenterWell Pharmacy will distribute Eli Lilly obesity medications under a new program targeting employers, according to a Jan. 12 news release. The pharmacy will serve those in employer ...
SAN FRANCISCO, Jan 12 (Reuters) - Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area over five years which will use Nvidia's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results